GGrantIndex
← Leaderboards

Martha A. Alexander-Miller

Wake Forest University Health Sciences

Google Scholar ↗PubMed ↗ORCID ↗
$16,765,845
Attributed
$16,765,845
Total exposure
13
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,765,845 · 13

By mechanism

R01$10,672,675 · 5
P01$2,334,307 · 2
T32$2,006,138 · 1
R21$1,752,725 · 5

Top collaborators

No co-investigators on record.

Most similar at Wake Forest University Health Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Response”

Research focus

ResponseCellsImmune ResponseAntigensVaccinesT-LymphocyteImmuneGenerationsImmunologyRegulationVirusVirus DiseasesInsightDoseInfectionSignal TransductionCytokineVaccinationBaseCd8b1 GeneImmune SystemTraining ProgramsInfluenzaEffector Cell

Grant awards (54)

The interplay of maternal antibody and newborn vaccine responses$793,102
R01 · FY2025 · AI · contact PI
Regulation of the HA stem nanoparticle vaccine response by antigen duration$228,195
R21 · FY2025 · AI · contact PI
Training Program in Immunology and Pathogenesis$225,204
T32 · FY2025 · AI · contact PI
Development of vaccine approaches to elicit broadly protective influenza-specific immune responses in infants$721,045
R01 · FY2024 · AI · contact PI
Training Program in Immunology and Pathogenesis$208,488
T32 · FY2024 · AI · contact PI
Training Program in Immunology and Pathogenesis$205,213
T32 · FY2023 · AI · contact PI
Development of vaccine approaches to elicit broadly protective influenza-specific immune responses in infants$748,799
R01 · FY2022 · AI · contact PI
Training Program in Immunology and Pathogenesis$196,646
T32 · FY2022 · AI · contact PI
Development of vaccine approaches to elicit broadly protective influenza-specific immune responses in infants$739,088
R01 · FY2021 · AI · contact PI
Training Program in Immunology and Pathogenesis$187,910
T32 · FY2021 · AI · contact PI
Development of vaccine approaches to elicit broadly protective influenza-specific immune responses in infants$754,126
R01 · FY2020 · AI · contact PI
Effectiveness of R848 conjugated IPR8 as a vaccine for the elderly$193,750
R21 · FY2020 · AI · contact PI
Training Program in Immunology and Pathogenesis$193,514
T32 · FY2020 · AI · contact PI
Effectiveness of R848 conjugated IPR8 as a vaccine for the elderly$232,500
R21 · FY2019 · AI · contact PI
Training Program in Immunology and Pathogenesis$190,755
T32 · FY2019 · AI · contact PI
Immune regulation by pneumococcus$193,750
R21 · FY2018 · AI · contact PI
Training Program in Immunology and Pathogenesis$188,652
T32 · FY2018 · AI · contact PI
Immune regulation by pneumococcus$232,500
R21 · FY2017 · AI · contact PI
Regulation of avidity in T lymphocytes$190,640
R21 · FY2017 · AI · contact PI
Regulation of avidity in T lymphocytes$229,390
R21 · FY2016 · AI · contact PI
Training Program in Immunology and Pathogenesis$152,128
T32 · FY2016 · AI · contact PI
Vaccination strategies to overcome immune deficiencies in neonates$573,639
R01 · FY2015 · AI · contact PI
Training Program in Immunology and Pathogenesis$159,878
T32 · FY2015 · AI · contact PI
Vaccination strategies to overcome immune deficiencies in neonates$584,860
R01 · FY2014 · AI · contact PI
Training Program in Immunology and Pathogenesis$97,750
T32 · FY2014 · AI · contact PI
Vaccination strategies to overcome immune deficiencies in neonates$552,662
R01 · FY2013 · AI · contact PI
Vaccination strategies to overcome immune deficiencies in neonates$623,271
R01 · FY2012 · AI · contact PI
Cellular Immune Response to Respiratory Infection$394,136
R01 · FY2010 · HL · contact PI
Cellular Immune Response to Respiratory Infection$397,970
R01 · FY2009 · HL · contact PI
Control of cytotoxic T cell differentiation and activity$266,957
R01 · FY2009 · AI · contact PI
Cellular Immune Responses to Respiratory Infection$306,143
R01 · FY2008 · HL · contact PI
Viral Regulation for the Respiratory Immune Response$280,229
P01 · FY2008 · AI · contact PI
Control of cytotoxic T cell differentiation and activity$266,957
R01 · FY2008 · AI · contact PI
Immunology Core Laboratory$151,701
P01 · FY2008 · AI · contact PI
Cellular Immune Responses to Respiratory Infection$306,143
R01 · FY2007 · HL · contact PI
Control of cytotoxic T cell differentiation and activity$272,128
R01 · FY2007 · AI · contact PI
Viral Regulation for the Respiratory Immune Response$266,035
P01 · FY2007 · AI · contact PI
Immunology Core Laboratory$210,439
P01 · FY2007 · AI · contact PI
Cellular Immune Responses to Respiratory Infection$315,287
R01 · FY2006 · HL · contact PI
Control of cytotoxic T cell differentiation and activity$280,256
R01 · FY2006 · AI · contact PI
Viral Regulation for the Respiratory Immune Response$266,945
P01 · FY2006 · AI · contact PI
Immunology Core Laboratory$211,161
P01 · FY2006 · AI · contact PI
Cellular Immune Responses to Respiratory Infection$322,875
R01 · FY2005 · HL
Control of cytotoxic T cell differentiation and activity$287,000
R01 · FY2005 · AI
Viral Regulation for the Respiratory Immune Response$259,551
P01 · FY2005 · AI
Immunology Core Laboratory$205,312
P01 · FY2005 · AI
Cellular Immune Responses to Respiratory Infection$323,156
R01 · FY2004 · HL
Viral Regulation for the Respiratory Immune Response$269,641
P01 · FY2004 · AI
Immunology Core Laboratory$213,293
P01 · FY2004 · AI
Control of T cell response during respiratory infection$252,000
R21 · FY2003 · AI
CONTROL OF CYTOTOXIC T CELL DIFFERENTIATION/ACTIVITY$220,204
R01 · FY2003 · AI
CONTROL OF CYTOTOXIC T CELL DIFFERENTIATION/ACTIVITY$213,791
R01 · FY2002 · AI
CONTROL OF CYTOTOXIC T CELL DIFFERENTIATION/ACTIVITY$207,563
R01 · FY2001 · AI
CONTROL OF CYTOTOXIC T CELL DIFFERENTIATION/ACTIVITY$201,517
R01 · FY2000 · AI